Medtronic: De-mystifying the Risks by Clarifying the Safety Profile of INFUSEŽ Bone Graft
4:30 PM-5:30 PM
W414A (Orange County Convention Center)
Robert E. Marx DDS
Miami, FL, USA
There have been questions raised regarding the association between the clinical use of INFUSEŽ Bone Graft and the incidence of cancer. This presentation will provide a thorough review of the pre-clinical and clinical studies that were conducted to illustrate the safety of INFUSEŽ Bone Graft. This scientific review will specifically address: 1.The potential for rhBMP-2 to promote cancer growth and/or development; 2.The potential for rhBMP-2 and/or the ACS carrier to cause an exposed individual to raise antibodies to either substance; 3.The potential of rhBMP-2 to affect pregnancy in females; and 4.The potential for rhBMP-2 to negatively impact the reproductive capabilities of males and/or females.